Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The transcription factor C/EBPalpha (for CCAAT/enhancer binding protein-alpha; encoded by the gene CEBPA) is crucial for the differentiation of granulocytes. Conditional expression of C/EBPalpha triggers neutrophilic differentiation, and no mature granulocytes are observed in Cebpa-mutant mice. Here we identify heterozygous mutations in CEBPA in ten patients with acute myeloid leukemia (AML). We found that five mutations in the amino terminus truncate the full-length protein, but did not affect a 30-kD protein initiated further downstream. The mutant proteins block wild-type C/EBPalpha DNA binding and transactivation of granulocyte target genes in a dominant-negative manner, and fails to induce granulocytic differentiation. Ours is the first report of CEBPA mutations in human neoplasia, and such mutations are likely to induce the differentiation block found in AML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We have recently shown mutations in the DNA-binding domain of C/EBP␣ in acute myeloid leukemia, suggesting its importance in granulocyte differentiation and leukemia.19”
From Granulocyte inducer C/EBPα inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions (2002) · cites this paper as [19]
Citations
Cites
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.229 · Cited by 3,486 · cited 1×
“These findings support the concept that CEBPA forms detected with monospecific antibodies are alternative products translated from several in-frame initiation codons by a leaky ribosome-scanning mechanis”
BackgroundThe Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Cao, Z., Umek, R. M., & McKnight, S. L. (1991) · Genes & Development · doi:10.1101/gad.5.9.1538 · Cited by 1,663
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Descombes, P., & Schibler, U. (1991) · Cell · doi:10.1016/0092-8674(91)90531-3 · Cited by 990
Isolation of a recombinant copy of the gene encoding C/EBP.
Landschulz, W. H., Johnson, P. F., Adashi, E. Y., Graves, B. J., & McKnight, S. L. (1988) · Genes & Development · doi:10.1101/gad.2.7.786 · Cited by 956
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 1×
“In addition, no mature granulocytes are observed in Cebpa -mutant mice, whereas all the other blood cell types are present in normal proportion”
BackgroundSelf-citationTranscription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“gif" NDATA ITEM> ]> Introduction A number of oncogenes that affect proliferation and cell death have been identified in leukemias and other cancers, but relatively few differentiation genes have been implicated in the malignant phenotyp”
BackgroundSelf-citationCCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch
Umek, R. M., Friedman, A. D., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1987644 · Cited by 712 · cited 1×
“bThe abnormalities were one del(9)(q21), one del(9)(q22q34), one t(6;9), one t(10;21)(p11;q22), one del(7)(q22q34), one +8, one +14, and four complex abnormalities.”
BackgroundRadomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., & Tenen, D. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4301 · Cited by 466 · cited 1×
“cThese patients had a 46,XY,del(12)(p11.”
Self-citation
Cited by
Items 901–930 of 930
A Review of CEBPA's Role in Hereditary Leukemia
Rakiewicz, T., & Palmisiano, N. D. (2026) · eJHaem · doi:10.1002/jha2.70236
Rocquain, J. (2010) · theses.fr (ABES) · doi:10.70675/e8009b43z68f2z48ecz8fe4z442a23be8e4d
Study of marrow microenvironment and focal adherences in myelodysplastic syndromes and leukemias
Aanei, C. M. (2012) · theses.fr (ABES) · doi:10.70675/28375e80z8fe7z4e43zb5aazdc45e09b8b71
Astori, A. (2014) · theses.fr (ABES) · doi:10.70675/f80a0d08z7b2ez422ez8f84z158ea6d20baa
Caractérisation des NADPH oxydases et effet de leur inhibition dans les leucémies aigues myéloïdes
Dakik, H. (2017) · theses.fr (ABES) · doi:10.70675/c50123fez19eaz4414zaf63z4c616441a1d3
Sabatier, M. (2021) · theses.fr (ABES) · doi:10.70675/b979658az593fz4730zbe37zbff2ac677eb7
Rôle des modifications des ARN dans la fidélité de la traduction chez les eucaryotes
Valadon, C. (2022) · theses.fr (ABES) · doi:10.70675/5fb31250z16d8z4cbbzac85zb79529529699
HLA Class II Protein Expression Regulation Is Strongly Linked to Cis‐Acting SNPs
Vince, N., Ramsuran, V., Viard, M., Martinson, J. J., Wolinsky, S. M., Hussain, S., Seaberg, E. C., Brown, T. T., Spence, N., Thio, C. L., et al. (2026) · HLA · doi:10.1111/tan.70669
Cirovic, B. (2026) · Cellular Reprogramming · doi:10.1177/21524971261464818
“Mutations of CEBPA are found in * 10% of AML patients and the involvement in the disease mechanism is associated with aberrant interaction with components of the cell cycle machinery and differentiation block (Nerlov, 2007; Pabst et al., 2001; Pabst and Mueller, 2009).”
Bilwani, F., Iqbal, F., & Khurshid, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12388-4
Peramangalam, P. S., Konde, M. V., Karakaslar, E. O., Wolf, S., Zheng, S., Salimov, A., Surapally, S., Griffioen, M., Gu, T., Rao, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.03.742558
Self-citationVrakas, C. N., Kawai, T., Ray, M., Herman, A. B., Etwebi, Z., Kelemen, S. E., Scalia, R. G., & Autieri, M. V. (2026) · The FASEB Journal · doi:10.1096/fj.202502231r
钟晓明, Roberts, K. G., Wei, H., Sun, Z., Montefiori, L. E., Kumar, A., Iacobucci, I., Baviskar, P., Gao, Q., Pölönen, P., et al. (2026) · Blood · doi:10.1182/blood.2026033793
Jain, K., Zhang, H., LaVoie, H. A., & Ren, Y. A. (2026) · Reproduction · doi:10.1093/reprod/xaag126
Zhang, X., Feng, D., Cao, Y., Xu, M., Liu, Y., Zhang, W., Zhang, R., Wei, J., Zhai, W., Pang, A., et al. (2026) · Bone Marrow Transplantation · doi:10.1038/s41409-026-03068-9
Nag, S., Maiti, S., Choudhury, S., & Adhikary, K. (2026) · Human Gene · doi:10.1016/j.humgen.2026.201613
BindingDB (2021) · UC San Diego · doi:10.7270/q289198w
Insertions and deletions (indels)
Roy, S., & Sehn, J. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-90024-9.00029-9
Veiga, D. F. T., Tremblay, M., Gerby, B., Herblot, S., Haman, A., Gendron, P., Lemieux, S., Zúñiga-Pflücker, J. C., Hébert, J., Cohen, J. P., et al. (2022) · doi:10.3389/fimmu.2022.867443.s008
Identification de nouvelles cibles pro-apoptotiques dans les leucémies aiguës myéloblastiques
Piedfer, M. (2012) · theses.fr (ABES) · doi:10.70675/2956fb95z7b93z4b3bz82edz5ab3bc4ba16a
Patel, K. P., Galbincea, J. M., & Luthra, R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2170-2_18
“[ 6 ] EGFR Solid Lynch et al.”
BackgroundC/EBPαp30 SUMO wrestles C/EBPαp42
Dahl, R. E. (2007) · Blood · doi:10.1182/blood-2007-08-106724
Laslo, P., & Stopka, T. (2014) · Epigenetics and human health · doi:10.1007/978-3-642-45198-0_9
Signaling Targets in Myeloid Leukemias
Futami, M., & Corey, S. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00327-2
(2018) · doi:10.22099/mbrc.2018.27625.1297
“Pabst et al, represented that 7.3% of AML patients carried spontaneous CEBPα mutations in the tumor cell DNA [12].”
BackgroundInfluential
Metadata
- Authors
- Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G.
- Affiliations
- Harvard University (US)
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Tenen, Daniel G.
- Venue
- Nature Genetics
- Published
- 2001-03
- Volume
- 27
- Issue
- 3
- Pages
- 263-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2100088478
- Cited by
- 901
- References
- 33
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 23 · 2023: 21 · 2022: 30 · 2021: 22 · 2020: 27 · 2019: 17 · 2018: 22 · 2017: 27 · 2016: 29 · 2015: 47 · 2014: 37 · 2013: 34 · 2012: 50
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL056745, HL56745)
- National Cancer Institute (CA-72009, P01CA072009)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- CEBPA, C/EBPα, acute myeloid leukemia, dominant negative mutation, heterozygous mutation, transcription factors, granulocytic differentiation, DNA binding, transcriptional activation, N-terminal truncation
- MeSH terms
- Base Sequence, Cell Differentiation, Cell Nucleus, DNA, Neoplasm, Genes, Dominant, Granulocytes, Heterozygote, Humans, Mutation, Neutrophils, Leukemia, Myeloid, Acute, Transcriptional Activation, Sequence Deletion, DNA Primers, CCAAT-Enhancer-Binding Protein-alpha, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.